AEYE Health (@AeyeHealth) header
AEYE Health (@AeyeHealth) profile picture

Leaders in Autonomous Diagnostic Screening for Retinal Diseases

Joined February 2022
Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)Photo by AEYE Health (@AeyeHealth)
This #DiabetesAwarenessMonth, early action must include the eyes. Over 60% of people with diabetes miss their yearly eye exam. FDA-cleared, Prix Galien award-winning AEYE-DS brings it into the routine visit: 1 minute, 1 image per eye, instant results. aeyehealth.com/post/world-di…
15
Heading to #HLTHUSA? Schedule a 1:1 with our team or visit Booth #829-6 in the Global Health Connector Pavilion (Nov 15-18) for a live demo of AEYE-DS! Over 60% of diabetic patients miss their eye exam. See how autonomous AI fixes that at point of care with the only FDA-cleared portable solution: calendly.com/aeyehealth/amer…
1
1
28
𝐀𝐄𝐘𝐄 𝐇𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐃𝐫. 𝐙𝐚𝐜𝐤 𝐃𝐯𝐞𝐲-𝐀𝐡𝐚𝐫𝐨𝐧 𝐖𝐢𝐧 𝐏𝐫𝐞𝐬𝐭𝐢𝐠𝐢𝐨𝐮𝐬 𝟐𝟎𝟐𝟔 𝐏𝐫𝐢𝐱 𝐆𝐚𝐥𝐢𝐞𝐧 𝐔𝐒𝐀 𝐀𝐰𝐚𝐫𝐝 𝐟𝐨𝐫 𝐆𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐀𝐈 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐧𝐠 𝐁𝐥𝐢𝐧𝐝𝐧𝐞𝐬𝐬! The #PrixGalien @GalienFdn honors technologies that transform care. AEYE-DS received this honor for developing the world’s first FDA-cleared portable, fully autonomous AI diagnostic solution, making diabetic eye exams accessible. 👇 Link below
1
1
53
One hour of training. 96% imageability. Zero pupil dilation. That's diabetic eye screening with AEYE-DS in a busy, real-world clinic, from a new study just published in the British Journal of Ophthalmology. Read more here: aeyehealth.com/news
54
Happy National Nurses Month! 💙 To the front-line nurses who show up every day with compassion, resilience, and unwavering dedication - thank you! From chronic disease management and early detection to care coordination, practice operations, and patient support, nurses are at the center of healthcare. At AEYE Health, we’re proud to support care teams with a solution that seamlessly integrates diabetic retinopathy screening into everyday visits, making it easier to deliver preventive care, close gaps, and protect patient’s vision. Your impact extends across the entire patient journey, and goes far beyond what can be measured. Thank you for your commitment to elevating patient care every single day! #NationalNursesMonth #PrimaryCare #DiabeticRetinopathy #PreventiveHealth
35
𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗶𝘀 𝗴𝗿𝗲𝗮𝘁. 𝗔𝗰𝗰𝗲𝘀𝘀 𝗶𝘀 𝗯𝗲𝘁𝘁𝗲𝗿. This Healthy Vision Month, we’re looking past patient-facing campaigns to a harder truth: The bottleneck in diabetic eye care isn't a lack of awareness- it's structural friction Despite clear guidelines, 60% of patients still miss their annual screenings. Traditional referral loops and high "ungradable" rates in teleretinal programs create a persistent blind spot in population health. The shift toward Point-of-Care: As highlighted in the 2026 ADA Standards of Care, moving screening into the primary care setting is the only way to optimize the "last mile" of delivery. This is where AI is becoming a core infrastructure layer in diabetic eye care, enabling scalable population health through immediate screening in primary care and real-time detection of referable disease. It reduces reliance on specialists and replaces referral-based bottlenecks with point-of-care delivery. That’s why more health systems are moving diabetic eye screening into primary care. With AEYE-DS, our autonomous AI diabetic retinopathy solution, providers can evaluate patients during routine visits and receive immediate results. As the only FDA-cleared solution compatible with a portable camera, AEYE-DS enables true point-of-care deployment with just one image per eye in under a minute, making diabetic eye screening a seamless part of routine workflows. As healthcare continues shifting toward value-based care, the question isn’t whether this matters. It’s whether our workflows make it easy enough to happen consistently. Healthy Vision Month highlights the importance of aligning infrastructure with real-world patient needs and the role of AI-enabled solutions in making that alignment possible. 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝘁𝗼 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝗵𝗼𝘄 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝗮𝗻𝗱 𝗶𝗻𝗳𝗿𝗮𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲 𝗰𝗮𝗻 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝗱𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗲𝘆𝗲 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗮𝘁 𝘀𝗰𝗮𝗹𝗲: lnkd.in/drY7NQmk #HealthyVisionMonth #PopulationHealth #DiabetesCare #DiabeticRetinopathy #PrimaryCare #ValueBasedCare
33
𝗦𝘂𝗰𝗰𝗲𝘀𝘀 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘀𝘁𝗮𝗿𝘁𝘀 𝘄𝗶𝘁𝗵 𝗮 𝘀𝗵𝗮𝗿𝗲𝗱 𝘃𝗶𝘀𝗶𝗼𝗻. 👁️ Last week, our sales team gathered at our New York City office for an intensive 2-day planning session. We weren’t just talking numbers; we were aligning on our 2026 roadmap to better support providers in closing the gap in diabetic retinopathy screening. Our mission remains clear: to eliminate preventable vision loss by removing barriers to diabetic eye care and ensuring AEYE-DS is seamlessly integrated into every patient visit. Beyond the strategy sessions, we also stepped into the kitchen for a team cooking workshop🥘. It was a great way to recharge and a reminder that while our AI is autonomous, our success is built on the people. #TeamWork #SalesTeam #NYC #GoToMarket
39
𝗔𝗗𝗔 𝟮𝟬𝟮𝟲 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝘀 𝗼𝗳 𝗖𝗮𝗿𝗲: 𝗧𝗵𝗲 𝗢𝗳𝗳𝗶𝗰𝗶𝗮𝗹 𝗦𝗵𝗶𝗳𝘁 𝘁𝗼 𝗔𝘂𝘁𝗼𝗻𝗼𝗺𝗼𝘂𝘀 𝗔𝗜 𝗶𝗻 𝗣𝗿𝗶𝗺𝗮𝗿𝘆 𝗖𝗮𝗿𝗲 The release of the American Diabetes Association's (ADA) 2026 Standards of Care in Diabetes represents more than a clinical update; it is a structural transformation in the delivery of diabetic eye care. For years, the referral-based models for diabetic retinopathy screening have struggled to close the care gap: the long wait time and fragmented workflows mean the vast majority of patients miss their essential annual screenings. AEYE-DS closes the diabetic eye care gap by bringing screening directly to the point of care. With the ADA guidelines now recognizing autonomous AI as a leading standard for primary care, AEYE-DS transforms vision preservation into a seamless, accessible part of every routine visit. 𝗔𝗘𝗬𝗘-𝗗𝗦: 𝗥𝗲𝗰𝗼𝗴𝗻𝗶𝘇𝗲𝗱 𝗮𝘀 𝘁𝗵𝗲 𝗡𝗲𝘄 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 Recognized within the highest tier of clinical validation, AEYE-DS fulfills the ADA’s goal of bringing vision-saving screening to where it’s needed most, in primary care: ⬥𝗣𝗼𝗿𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗨𝘀𝗮𝗯𝗶𝗹𝗶𝘁𝘆: As the only FDA-cleared AI for portable cameras and only AI that requires just 1 image per-eye for the analysis and no dilation, AEYE-DS delivers the fast, accessible, point-of-care diagnosis the 2026 ADA Standards now demand. ⬥𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗥𝗲𝘀𝘂𝗹𝘁𝘀: AEYE-DS delivers an autonomous diagnosis at the point of care, eliminating the need for physician interpretation, and ensuring patients are successfully screened and notified of their result during the same visit. ⬥>𝟵𝟵% 𝗜𝗺𝗮𝗴𝗲𝗮𝗯𝗶𝗹𝗶𝘁𝘆: A superior "success rate" that ensures virtually every patient can be screened successfully before they leave the clinic. ⬥𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗘𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆: Autonomous AI manages routine diagnostics, allowing specialists to focus on treatment while seamless EHR integration automates everything - documentation, billing, care cap closure coding and even referral triggers for the patients found positive for referable DR. ⬥𝗩𝗲𝗿𝗶𝗳𝗶𝗲𝗱 𝗥𝗲𝗶𝗺𝗯𝘂𝗿𝘀𝗲𝗺𝗲𝗻𝘁: Fully reimbursable under CPT 92229, finally enabling financial viability of AI-based screening. By adopting AEYE-DS, providers can move beyond the “referral black hole” and deliver the new gold standard in vision preservation. 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝘁𝗼 𝘀𝗲𝗲 𝗵𝗼𝘄 𝗔𝗜 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗶𝘀 𝗿𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗱𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗲𝘆𝗲 𝗰𝗮𝗿𝗲: aeyehealth.com/post/defining…
31
𝗧𝗵𝗿𝗲𝗲 𝗰𝗶𝘁𝗶𝗲𝘀. 𝗢𝗻𝗲 𝗴𝗼𝗮𝗹: 𝗖𝗹𝗼𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗱𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗲𝘆𝗲 𝗲𝘅𝗮𝗺 𝗰𝗮𝗿𝗲 𝗴𝗮𝗽. This April we had the privilege of joining the C. Frank Webber Lectureship and Interim Session hosted by the @TXFamilyDocs - the Texas Academy of Family Physicians, Ignite, the Florida Academy of Family Physicians (FAFP) flagship spring forum, and the American Medical Group Association (AMGA) 2026 Annual Conference. Each event had its own focus, but one question united every leader we met: How do we close the diabetic eye exam care gap? There is a growing realization that the current referral-heavy model to eye specialists does not achieve high enough adherence and creates a real barrier to care, as the vast majority don’t follow through. This realization has led to a shared commitment to ensuring no patient loses their sight due to a preventable gap. It was especially exciting to see strong interest and engagement around AEYE-DS, our FDA-cleared solution that is now the fastest-growing solution in America. A fully autonomous AI diabetic retinopathy screening solution that can be performed anywhere, in under a minute, using just one image per eye to deliver on-the-spot results at the point of care. Enabling immediate diagnosis helps enable more efficient, point-of-care workflows and helps bring advanced care directly into everyday clinical practice. We’re grateful for the opportunity to connect, share, and learn from so many forward-thinking clinicians and healthcare leaders who are committed to improving patient outcomes.
1
68
Primary care is at a breaking point. Between the mounting pressure to deliver earlier interventions and the struggle to manage expanding patient panels, "closing care gaps" often feels like a moving target, especially for diabetic retinopathy. Traditionally, screening requires external referrals and separate specialist visits, resulting in low patient follow-through. For health systems, this friction creates persistent care gaps, lower HEDIS scores, and leads to the most frustrating outcome of all: preventable vision loss. 𝗧𝗵𝗮𝘁’𝘀 𝘄𝗵𝘆 𝘄𝗲’𝗿𝗲 𝗮𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗠𝗚𝗔 𝟮𝟬𝟮𝟲 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲. AMGA brings together leaders from integrated health systems and medical groups who are actively shaping the future of value-based care, population health, clinical transformation, and multispecialty integration. We are joining this conversation to help health systems move from "managing" gaps to eliminating them through autonomous AI. If you plan to attend, we’d love to connect and demonstrate how AEYE-DS is revolutionizing the standard of care. Our FDA-cleared, fully autonomous AI enables you to close care gaps instantly by delivering a 1-minute diabetic retinopathy diagnosis on the spot - all from a single image per eye. By integrating directly into your EHR, AEYE-DS eliminates administrative friction, maximizes HEDIS scores, and allows you to capture CPT 92229 revenue right at the point of care. Let’s discuss how we can turn a complex referral process into a seamless, one-minute clinical victory for your providers and patients Click the link to book a meeting at the event: aeyehealth.com/lp 📍 Las Vegas, NV | April 15–18, 2026
🤖 Made with AI
26
You’re doing the right thing by referring patients for diabetic eye exams - but too many never make it to that appointment. If you’re attending 𝗜𝗴𝗻𝗶𝘁𝗲, the 𝗙𝗹𝗼𝗿𝗶𝗱𝗮 𝗔𝗰𝗮𝗱𝗲𝗺𝘆 𝗼𝗳 𝗙𝗮𝗺𝗶𝗹𝘆 𝗣𝗵𝘆𝘀𝗶𝗰𝗶𝗮𝗻𝘀 (𝗙𝗔𝗙𝗣) flagship spring forum, there’s a better way to ensure your patients actually get screened! AEYE-DS brings AI diabetic eye exams directly into your visit, delivering a complete, fully autonomous diagnostic result within seconds - before the patient walks out the door. Close the diabetic eye care gap with no physician interpretation, just immediate diagnosis at the point of care. As the only FDA-cleared autonomous AI designed for use with a portable camera - and the only AI that requires just one image per eye - it fits seamlessly into real-world primary care workflows. If you’re attending Ignite, we’d love to connect and explore how AEYE-DS can bring point-of-care diabetic screening directly into your practice. Visit our booth or schedule a time to meet with our team: lnkd.in/drRMAGnZ See you there! 📍 Orlando, FL | April 17-19, 2026
27